Comparing clinical outcomes of ARB and ACEi in patients hospitalized for acute COVID-19

Continued receipt of Renin–Angiotensin–Aldosterone inhibitors in patients with COVID-19 has shown potential in producing better clinical outcomes. However, superiority between ACEi (angiotensin-converting enzyme inhibitors) and ARB (angiotensin II receptor blockers) regarding clinical outcomes in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamada, Seiji, Suzuki, Tomoharu, Tokuda, Yasuharu, Taniguchi, Kiyosu, Shibuya, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361955/
https://www.ncbi.nlm.nih.gov/pubmed/37479767
http://dx.doi.org/10.1038/s41598-023-38838-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361955/
https://www.ncbi.nlm.nih.gov/pubmed/37479767
http://dx.doi.org/10.1038/s41598-023-38838-8

Ejemplares similares